Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 or 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 5, 2019

 

 

Mohawk Group Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-38937   83-1739858

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

Mohawk Group Holdings, Inc.

37 East 18th Street, 7th Floor

New York, NY 10003

(Address of Principal Executive Offices)(Zip Code)

(347) 676-1681

(Registrant’s telephone number, including area code)

N/A

(Former Name, or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol

 

Name of each exchange

on which registered

Common Stock, $0.0001 par value   MWK   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On November 5, 2019, Mohawk Group Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2019. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this Item 2.02, including the press release attached hereto as Exhibit 99.1, is intended to be furnished under Item 2.02 and Item 9.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

99.1    Press Release issued by Mohawk Group Holdings, Inc., dated November 5, 2019


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MOHAWK GROUP HOLDINGS, INC.
Date: November 5, 2019     By:   /s/ Yaniv Sarig
      Yaniv Sarig
      President and Chief Executive Officer
EX-99.1

Exhibit 99.1

 

LOGO

Mohawk Group Reports Third Quarter 2019 Results

Third Quarter Net Revenue Grew 65% Year-over-Year to $40.6 Million

NEW YORK, November 5, 2019 – Mohawk Group Holdings, Inc. (NASDAQ: MWK) (“Mohawk” or the “Company”) today announced results for the third quarter ended September 30, 2019.

 

   

3 new products launched in the third quarter and 17 new product launches on track for the fourth quarter to date

 

   

Net revenue grew 64.6% to $40.6 million, compared to $24.7 million in the third quarter of 2018

 

   

Gross margin increased to 43.2%, compared to 42.2% in the third quarter of 2018 and 38.7% in the second quarter of 2019

 

   

Operating loss for the third quarter of 2019, inclusive of $7.7 million in non-cash stock-based compensation, was $(10.4) million compared to $(4.7) million in the third quarter of 2018, which included $0.1 million in non-cash stock-based compensation

 

   

Contribution margin improved to $3.2 million, compared to $0.3 million in the third quarter of 2018 and $1.7 million in the second quarter of 2019

 

   

Net loss for the third quarter of 2019, inclusive of $7.7 million in non-cash stock-based compensation, was $(11.3) million compared to $(5.1) million in the third quarter of 2018, which included $0.1 in non-cash stock-based compensation

 

   

Adjusted EBITDA improved to $(2.7) million, compared to $(4.5) million in the third quarter of 2018 and $(3.7) million in the second quarter of 2019

 

   

Cash provided by operating activities was $3.1 million, compared to cash used in operating activities of $(4.4) million in the second quarter of 2019

 

   

Total cash balance at September 30, 2019 was $35.7 million

Yaniv Sarig, Co-Founder and Chief Executive Officer, commented, “We grew at a rapid pace during the third quarter as our tech-enabled business model driven by data, automation and artificial intelligence continues to fuel market-share gains. With our proprietary software platform AIMEE, we are at the forefront of disrupting the consumer products industry and capitalizing on the growing shift to digital commerce. We have launched 14 new products year-to-date, and our new product pipeline is accelerating. Equally important, the success rate of our new product launches continues to improve and now stands at approximately 80%, as our AI platform and quality-control processes continue to improve. Looking ahead, we are on track for a busy finish to the year with 17 new products launching over the course of the fourth quarter.”

Third Quarter 2019 Review

Third quarter 2019 net revenue increased 64.6% to $40.6 million, compared to $24.7 million in the third quarter of 2018. The increase was primarily attributable to increased direct sales volume, which grew by $15.6 million, or 63.9% from the third quarter of 2018, from growth of existing products as well as new products launched in the second half of 2018 and in 2019.

Gross margin for the third quarter of 2019 was 43.2%, compared to 42.2% in the year ago period and 38.7% in the second quarter of 2019.

 

1


LOGO

 

Total operating expenses for the third quarter of 2019 increased to $27.9 million from $15.1 million a year ago driven primarily by a $7.6 million increase in non-cash stock-based compensation expense. Total operating expenses as a percentage of net revenue was 68.8% in the third quarter of 2019 versus 61.3% the third quarter of 2018. Excluding non-cash stock-based compensation expense, operating expenses as a percentage of net revenue decreased to 49.8% from 60.7% in the same period last year. The significant improvement in operating expense leverage highlights the Company’s current ability to launch new products and grow revenue while keeping fixed costs essentially flat due to the Company’s AIMEE automation.

Sales and distribution expenses as a percentage of net revenue was 42.6% in the third quarter of 2019 versus 46.9% the third quarter of 2018. Sales and distribution expenses excluding $1.6 million in non-cash stock-based compensation as a percentage of net revenue decreased to 38.6% from 46.8% in the same period last year also excluding non-cash stock-based compensation. The change was primarily attributable to a higher percentage of sales fulfilled by the Company’s own third party warehouse providers instead of through e-commerce platform service providers.

Research and development expenses for the third quarter of 2019 was $2.6 million compared to $0.8 million in the third quarter of 2018. Research-and-development expenses excluding $1.3 million in non-cash stock-based compensation increased to $1.3 million from $0.8 million in the year-ago period due to an increase in the number of developers to support growth.

General and administrative expenses for the third quarter of 2019 was $8.0 million compared to $2.8 million in the third quarter of 2018. General and administrative expenses, excluding $4.6 million in non-cash stock-based compensation, increased to $3.4 million compared to $2.6 million in the year-ago period, due primarily to costs associated with being a public company.

Operating loss for the third quarter of 2019 was $(10.4) million compared to $(4.7) million in the third quarter of 2018. Excluding non-cash stock-based compensation, third quarter 2019 operating loss was $(2.7) million.

Contribution margin for the third quarter of 2019 improved to $3.2 million compared to $0.3 million in the third quarter of 2018 and $1.7 million in the second quarter of 2019. Contribution margin as a percentage of net revenue for the quarter was 8.0% compared to 1.1% in the third quarter of 2018 and 5.7% in the second quarter of 2019.

Net loss for the third quarter of 2019 was $(11.3) million compared to $(5.1) million in the third quarter of 2018. Net loss for the third quarter of 2019 includes $7.7 million of stock-based compensation expense.

Adjusted EBITDA for the third quarter of 2019 improved to $(2.7) million compared to $(4.5) million in the third quarter of 2018 and $(3.7) million in the second quarter of 2019.

Balance Sheet and Cash Flow

As of September 30, 2019, the Company had cash and cash equivalents of $35.7 million, compared with $20.0 million at December 31, 2018, and $39.5 million as of June 30, 2019.

On September 10, 2019, Mohawk acquired the assets of Aussie Health, a personal health company, for $1.3 million. The Company used $1.1 million in cash and a $0.2 million promissory note to fund the purchase. Aussie Health’s trailing twelve months revenue as of September 30, 2019 was $2.2 million and trailing twelve months operating income as of September 30, 2019 was $0.4 million. No headcount was added in connection with this acquisition.

 

2


LOGO

 

Cash provided by operating activities was $3.1 million, compared to cash used in operating activities of $(4.4) million in the second quarter of 2019. Total net change in cash and restricted cash for the quarter was a use of $(3.8) million. Overall, cash burn improved for the quarter to $(2.4) million compared to $(4.3) million in second quarter 2019.

Non-GAAP Financial Measures

For more information on our non-GAAP financial measures and a reconciliation of GAAP to non-GAAP measures, please see the “Non-GAAP Financial Measures and Reconciliations” section below.

Webcast and Conference Call Information

Mohawk will host a live conference call to discuss financial results today, November 5, 2019, at 5:00 p.m. Eastern Time. Investors and analysts interested in participating in the call are invited to dial (877) 295-1077 (domestic) or (470) 495-9485 (international) at 5:00 p.m. ET and provide the Conference ID: 1387387. The conference call will also be available to interested parties through a live webcast at https://ir.mohawkgp.com/investor-relations. Please visit the website at least 15 minutes prior to the start of the call to register and download any necessary software.

About Mohawk Group Holdings, Inc.

Mohawk Group Holdings, Inc. and subsidiaries (“Mohawk”) is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing, and data analytics to design, develop, market, and sell products. Mohawk predominantly operates through online retail channels such as Amazon and Walmart. Mohawk has incubated and grouped four owned-and-operated brands: hOme, Vremi, Xtava, and RIF6. Mohawk sells products in multiple categories, including home and kitchen appliances, kitchenware, environmental appliances (i.e., dehumidifiers and air conditioners), beauty related products, and, to a lesser extent, consumer electronics. Mohawk was founded on the premise that if a company selling consumer packaged goods were founded today, it would apply artificial intelligence and machine learning, the synthesis of massive quantities of data, and the use of social proof to validate high-caliber product offerings as opposed to over-reliance on brand value and other traditional marketing tactics.

Forward Looking Statements

All statements other than statements of historical facts included in this press release that address activities, events, or developments that we expect, believe, or anticipate will or may occur in the future are forward-looking statements including, in particular, the statements about our ability to launch new products, our technology platform and its ability to disrupt the consumer products industry; the shift to digital commerce and growth thereof; our fulfillment capabilities; our ability to gain market share in existing categories; our ability to penetrate new categories; our top-line growth including as compared to operating costs; our expected launches; our acceleration of our product pipeline; and our ability to enhance profitability over time. These forward-looking statements are based on management’s current expectations and beliefs and are subject to uncertainties and other factors, all of which are difficult to

 

3


LOGO

 

predict and many of which are beyond our control and could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to, those related to our cash flows and revenue growth rate; our supply chain, sourcing, manufacturing and warehousing; international tariffs and trade measures; inventory management, product liability claims, recalls, or other safety concerns; reliance on third-party online marketplaces; seasonal and quarterly variations in our revenue; acquisitions of other companies and technologies; and other factors discussed in the “Risk Factors” section of our most recent periodic reports filed with the Securities and Exchange Commission (“SEC”), including in our final prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on June 13, 2019, all of which you may obtain for free on the SEC’s website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, even if subsequently made available by us on our website or otherwise. We do not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Investor Contacts:

Ilya Grozovsky, Mohawk Group

ilya@mohawkgp.com

917-905-1699

Brendon Frey, ICR

brendon.frey@icrinc.com

203-682-8200

Media Contact:

Stacey Sullivan, ICR

stacey.sullivan@icrinc.com

203-682-8200

 

4


LOGO

 

MOHAWK GROUP HOLDINGS, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

(in thousands, except share and per share data)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2018     2019     2018     2019  

NET REVENUE

   $ 24,672     $ 40,603     $ 53,576     $ 88,817  

COST OF GOODS SOLD (1)

     14,262       23,076       35,919       52,859  
  

 

 

   

 

 

   

 

 

   

 

 

 

GROSS PROFIT

     10,410       17,527       17,657       35,958  
  

 

 

   

 

 

   

 

 

   

 

 

 

OPERATING EXPENSES:

        

Sales and distribution (1)

     11,560       17,307       28,516       38,409  

Research and development (1)

     790       2,634       2,810       5,657  

General and administrative (1)

     2,767       7,999       8,103       15,779  
  

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL OPERATING EXPENSES:

     15,117       27,940       39,429       59,845  
  

 

 

   

 

 

   

 

 

   

 

 

 

OPERATING LOSS

     (4,707     (10,413     (21,772     (23,887

INTEREST EXPENSE—net

     439       875       1,503       3,368  

OTHER EXPENSE (INCOME)—net

     (19     21       (45     53  
  

 

 

   

 

 

   

 

 

   

 

 

 

LOSS BEFORE INCOME TAXES

     (5,127     (11,309     (23,230     (27,308

PROVISION FOR INCOME TAXES

     —         8       3       23  
  

 

 

   

 

 

   

 

 

   

 

 

 

NET LOSS

   $ (5,127   $ (11,317   $ (23,233   $ (27,331
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per share, basic and diluted

   $ (0.49   $ (0.75   $ (2.40   $ (2.11
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average number of shares outstanding, basic and diluted

     10,532,926       15,134,422       9,687,078       12,971,641  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

Amounts include stock-based compensation expense as follows:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2018      2019      2018      2019  
     (in thousands)      (in thousands)  

Cost of goods sold

   $ —        $ —        $ —        $ —    

Sales and distribution expenses

     5        1,617        11        2,533  

Research and development expenses

     8        1,327        21        1,878  

General and administrative expenses

     128        4,772        450        7,424  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation expense

   $ 141      $ 7,716      $ 482      $ 11,835  

 

5


LOGO

 

MOHAWK GROUP HOLDINGS, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

(in thousands, except share and per share data)

 

     December 31, 2018     September 30, 2019  

ASSETS

    

CURRENT ASSETS:

    

Cash

   $ 20,029     $ 35,686  

Accounts receivable—net

     1,403       3,152  

Inventory

     30,552       25,908  

Prepaid and other current assets

     5,418       6,736  
  

 

 

   

 

 

 

Total current assets

     57,402       71,482  

PROPERTY AND EQUIPMENT—net

     268       140  

GOODWILL AND OTHER INTANGIBLES—net

     —         1,071  

OTHER NON-CURRENT ASSETS

     337       135  
  

 

 

   

 

 

 

TOTAL ASSETS

   $ 58,007     $ 72,828  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

CURRENT LIABILITIES:

    

Credit facility

   $ 14,451     $ 13,640  

Accounts payable

     15,404       15,453  

Accrued and other current liabilities

     9,708       10,880  
  

 

 

   

 

 

 

Total current liabilities

     39,563       39,973  

OTHER LIABILITIES

     26       8  

TERM LOANS

     13,049       13,339  
  

 

 

   

 

 

 

Total liabilities

     52,638       53,320  

COMMITMENTS AND CONTINGENCIES

    

STOCKHOLDERS’ EQUITY:

    

Common stock, par value $0.0001 per share—500,000,000 shares authorized and 11,534,190 shares outstanding at December 31, 2018; 500,000,000 shares authorized and 17,710,659 shares outstanding at September 30, 2019

     1       2  

Additional paid-in capital

     76,348       117,791  

Accumulated deficit

     (71,020     (98,351

Accumulated other comprehensive income

     40       66  
  

 

 

   

 

 

 

Total stockholders’ equity

     5,369       19,508  
  

 

 

   

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 58,007     $ 72,828  
  

 

 

   

 

 

 

 

6


LOGO

 

MOHAWK GROUP HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited) (in thousands)

 

     Nine Months Ended September 30,  
     2018     2019  

OPERATING ACTIVITIES:

    

Net loss

   $ (23,233   $ (27,331

Adjustments to reconcile net loss to net cash used in operating activities:

    

Depreciation and amortization

     188       136  

Provision for sales returns

     118       236  

Amortization of deferred financing costs and debt discounts

     337       914  

Stock-based compensation

     482       11,835  

Other

     62       101  

Changes in assets and liabilities:

    

Accounts receivable

     48       (1,784

Inventory

     (515     4,944  

Prepaid and other current assets

     (2,757     (2,307

Accounts payable, accrued and other liabilities

     5,731       110  
  

 

 

   

 

 

 

Cash used in operating activities

     (19,529     (13,146

INVESTING ACTIVITIES:

    

Purchase of fixed assets

     (25     (48

Purchase of Aussie Health Co.’s assets

     —         (1,105

Proceeds on sale of fixed assets

     35       6  
  

 

 

   

 

 

 

Cash provided by (used in) investing activities

     10       (1,147

FINANCING ACTIVITIES:

    

Proceeds from exercise of stock options

     —         2  

Proceeds from issuance of Series C preferred stock—converted to common stock

     23,061       —    

Proceeds from issuance of Series C-1 preferred stock—converted to common stock

     8,364       —    

Proceeds from Initial Public Offering

     —         36,000  

Proceeds received from exercise of stock options

     18       —    

Issuance costs of Series C preferred stock— converted to common stock

     (3,000     —    

Issuance costs of Series C-1 preferred stock—converted to common stock

     (1,036     —    

Issuance costs from initial public offering

     —         (5,446

Borrowings from Mid Cap credit facility

     37,048       69,740  

Repayments from Mid Cap credit facility

     (32,519     (71,082

Repayments from Mid Cap term loan

     (1,344      

Debt issuance costs from Mid Cap credit facility

     (369     (581

Debt issuance costs from Horizon term loan

     —         (900

Deferred offering costs

     (17     —    

Insurance financing proceeds

     —         3,833  

Insurance obligation payments

     —         (1,818

Capital lease financing proceeds

     20       —    

Capital lease obligation payments

     (40     (42
  

 

 

   

 

 

 

Cash provided by financing activities

     30,186       29,706  

EFFECT OF EXCHANGE RATE ON CASH

     —         1  
  

 

 

   

 

 

 

NET CHANGE IN CASH AND RESTRICTED CASH FOR PERIOD

     10,667       15,414  

CASH AND RESTRICTED CASH AT BEGINNING OF PERIOD

     5,797       20,708  
  

 

 

   

 

 

 

CASH AND RESTRICTED CASH AT END OF PERIOD

   $ 16,464     $ 36,122  
  

 

 

   

 

 

 

RECONCILIATION OF CASH AND RESTRICTED CASH

    

CASH

   $ 15,785     $ 35,686  

RESTRICTED CASH—Prepaid and other assets

     550       307  

RESTRICTED CASH—Other non-current assets

     129       129  
  

 

 

   

 

 

 

TOTAL CASH AND RESTRICTED CASH

   $ 16,464     $ 36,122  
  

 

 

   

 

 

 

 

7


LOGO

 

     Nine Months Ended September 30,  
     2018      2019  

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

     

Cash paid for interest

   $ 1,112      $ 2,467  

Cash paid for taxes

   $ 3      $ 15  

NON-CASH INVESTING AND FINANCING ACTIVITIES:

     

Capital lease

   $ 25      $  

Note payable on acquisition

   $      $ 195  

 

     Three
Months
Ended
March 31,
    Three
Months
Ended

June 30,
    Three
Months
Ended
September 30,
 
     2019     2019     2019  
     (in thousands except share and per share data)  

NET REVENUE

   $ 17,846     $ 30,368     $ 40,603  

COST OF GOODS SOLD (1)

     11,175       18,608       23,076  
  

 

 

   

 

 

   

 

 

 

GROSS PROFIT

     6,671       11,760       17,527  
  

 

 

   

 

 

   

 

 

 

OPERATING EXPENSES:

      

Sales and distribution (1)

     9,274       11,828       17,307  

Research and development (1)

     1,163       1,860       2,634  

General and administrative (1)

     3,366       4,414       7,999  
  

 

 

   

 

 

   

 

 

 

TOTAL OPERATING EXPENSES:

     13,803       18,102       27,940  
  

 

 

   

 

 

   

 

 

 

OPERATING LOSS

     (7,132     (6,342     (10,413

INTEREST EXPENSE—net

     1,212       1,281       875  

OTHER EXPENSE (INCOME)—net

     45       (13     21  
  

 

 

   

 

 

   

 

 

 

LOSS BEFORE INCOME TAXES

     (8,389     (7,610     (11,309

PROVISION FOR INCOME TAXES

     —         15       8  
  

 

 

   

 

 

   

 

 

 

NET LOSS

   $ (8,389   $ (7,625   $ (11,317
  

 

 

   

 

 

   

 

 

 

Net loss per share, basic and diluted

   $ 0.73     $ 0.62     $ (0.75
  

 

 

   

 

 

   

 

 

 

Weighted-average number of shares outstanding, basic and diluted

     11,534,190       12,206,747       15,134,422  
  

 

 

   

 

 

   

 

 

 

 

(1)

Amounts include stock-based compensation expense as follows:

 

     Three Months
Ended

March 31,
     Three Months
Ended

June 30,
     Three Months
Ended
September 30,
 
     2019      2019      2019  
     (in thousands)  

Cost of goods sold

   $ —        $ —        $ —    

Sales and distribution expenses

     388        528        1,617  

Research and development expenses

     161        390        1,327  

General and administrative expenses

     951        1,701        4,772  
  

 

 

    

 

 

    

 

 

 

Total stock-based compensation expense

   $ 1,500      $ 2,619      $ 7,716  

 

8


LOGO

 

Non-GAAP Financial Measures and Reconciliations

The non-GAAP financial measures contained herein are a supplement to the corresponding financial measures prepared in accordance with U.S. GAAP. The non-GAAP financial measures presented exclude the items described below. Management believes that adjustments for these items assist investors in making comparisons of period-to-period operating results. Furthermore, management also believes that these items are not indicative of the Company’s on-going core operating performance. These non-GAAP financial measures have certain limitations in that they do not reflect all of the costs associated with the operations of the Company’s business as determined in accordance with GAAP.

Therefore, investors should consider non-GAAP financial measures in addition to, and not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. The non-GAAP financial measures presented by the Company may be different from the non-GAAP financial measures used by other companies.

The Company has presented the following non-GAAP measures to assist investors in understanding the Company’s core net operating results on an on-going basis: (i) Contribution margin; (ii) Contribution margin as a percentage of net revenue; (iii) Adjusted EBITDA; (iv) Adjusted EBITDA as a percentage of net revenue (v) operating expenses, including operating loss, excluding stock-based compensation and (vi) cash burn. These non-GAAP financial measures may also assist investors in making comparisons of the Company’s core operating results with those of other companies.

As used herein, Contribution margin represents operating loss plus general and administrative expenses, research and development expenses and fixed sales and distribution expenses. As used herein, Contribution margin as a percentage of net revenue represents Contribution margin divided by net revenue. As used herein, EBITDA represents net loss plus depreciation and amortization, interest expense, net and income tax expense. As used herein, Adjusted EBITDA represents EBITDA plus stock-based compensation expense and other expense, net. As used herein, Adjusted EBTIDA as a percentage of net revenue represents Adjusted EBITDA divided by net revenue. Contribution margin, EBITDA and Adjusted EBITDA do not represent and should not be considered as alternatives to loss from operations or net loss, as determined under GAAP.

We present Contribution margin, Contribution margin as a percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue because we believe each of these measures provides an additional metric to evaluate our operations and, when considered with both our GAAP results and the applicable GAAP reconciliation, provides useful supplemental information for investors. We use Contribution margin, Contribution margin as a percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue, together with financial measures prepared in accordance with GAAP, such as sales and gross margins, to assess our historical and prospective operating performance, to provide meaningful comparisons of operating performance across periods, to enhance our understanding of our operating performance and to compare our performance to that of our peers and competitors.

We believe EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue are useful to investors in assessing the operating performance of our business without the effects of non-cash items, while Contribution margin and Contribution margin as a percentage of net revenue are useful to investors in assessing the operating performance of our products as they represent our operating results without the effects of fixed costs and

 

9


LOGO

 

non-cash items. Contribution margin, Contribution margin as a percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue, should not be considered in isolation or as alternatives to net loss, loss from operations or any other measure of financial performance calculated and prescribed in accordance with GAAP. Neither EBITDA, Adjusted EBITDA nor Adjusted EBITDA as a percentage of net revenue should be considered a measure of discretionary cash available to us to invest in the growth of our business. Our Contribution margin, Contribution margin as a percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue may not be comparable to similarly titled measures in other organizations because other organizations may not calculate Contribution margin, EBITDA, Adjusted EBITDA or Adjusted EBITDA as a percentage of net revenue in the same manner as we do. Our presentation of Contribution margin and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from such terms or by unusual or non-recurring items.

We recognize that EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue have limitations as analytical financial measures. For example, neither EBITDA nor Adjusted EBITDA reflects:

 

   

our capital expenditures or future requirements for capital expenditures or mergers and acquisitions;

 

   

the interest expense or the cash requirements necessary to service interest expense or principal payments, associated with indebtedness;

 

   

depreciation and amortization, which are non-cash charges, although the assets being depreciated and amortized will likely have to be replaced in the future, or any cash requirements for the replacement of assets; or

 

   

changes in cash requirements for our working capital needs.

Additionally, Adjusted EBITDA excludes non-cash expense for stock-based compensation, which is and will remain a key element of our overall long-term incentive compensation package.

We also recognize that Contribution margin and Contribution margin as a percentage of net revenue have limitations as analytical financial measures. For example, Contribution margin does not reflect:

 

   

general and administrative expenses necessary to operate our business;

 

   

research and development expenses necessary for the development, operation and support of our software platform; or

 

   

the fixed costs portion of our sales and distribution expenses including stock-based compensation expense.

The following table provides a reconciliation of Contribution margin to operating loss, which is the most directly comparable financial measure presented in accordance with GAAP:

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2018     2019     2018     2019  
     (in thousands, except percentages)  

Operating loss

   $ (4,707   $ (10,413   $ (21,772   $ (23,887

Add (deduct)

        

General and administrative expenses

     2,767       7,999       8,103       15,779  

Research and development expenses

     790       2,634       2,810       5,657  

Sales and distribution fixed expenses, including stock-based compensation expense

     1,415       3,010       4,052       6,623  

Contribution margin

   $ 265     $ 3,230     $ (6,807   $ 4,172  
  

 

 

   

 

 

   

 

 

   

 

 

 

Contribution margin as a percentage of net revenue

     1.1     8.0     (12.7 )%      4.7

 

10


LOGO

 

     Three Months
Ended

March 31,
    Three Months
Ended

June 30,
    Three Months
Ended
September 30,
 
     2019     2019     2019  
     (in thousands, except percentages)  

Operating loss

   $ (7,132   $ (6,342   $ (10,413

Add (deduct)

      

General and administrative expenses

     3,366       4,414       7,999  

Research and development expenses

     1,163       1,860       2,634  

Sales and distribution fixed expenses, including stock-based compensation expense

     1,808       1,804       3,010  
  

 

 

   

 

 

   

 

 

 

Contribution margin

   $ (795)     $ 1,736     $ 3,230  
  

 

 

   

 

 

   

 

 

 

Contribution margin as a percentage of net revenue

     (4.5 )%      5.7     8.0
  

 

 

   

 

 

   

 

 

 

The following table provides a reconciliation of EBITDA and Adjusted EBITDA to net loss, which is the most directly comparable financial measure presented in accordance with GAAP:

 

     Three Months
Ended
September 30,
    Nine Months
Ended
September 30,
 
     2018     2019     2018     2019  
     (in thousands, except percentages)  

Net loss

   $ (5,127   $ (11,317   $ (23,233   $ (27,331

Add (deduct)

        

Provision for income taxes

     —         8       3       23  

Interest expense, net

     439       875       1,503       3,368  

Depreciation and amortization

     60       41       188       136  
  

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     (4,628     (10,393     (21,539     (23,804
  

 

 

   

 

 

   

 

 

   

 

 

 

Other expense (income), net

     (19     21       (45     53  

Stock-based compensation expense

     141       7,716       482       11,835  

Adjusted EBITDA

   $ (4,506   $ (2,656   $ (21,102   $ (11,916
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA as a percentage of net revenue

     (18.3 )%      (6.5 )%      (39.4 )%      (13.4 )% 

 

     Three Months
Ended

March 31,
     Three Months
Ended

June 30,
     Three
Months
Ended
September 30,
 
     2019      2019      2019  
     (in thousands, except percentages)  

Net loss

   $ (8,389    $ (7,625    $ (11,317

Add (deduct)

        

Provision for income taxes

     —          15        8  

Interest expense, net

     1,212        1,281        875  

 

11


LOGO

 

Depreciation and amortization

     55       40       41  
  

 

 

   

 

 

   

 

 

 

EBITDA

     (7,122     (6,289     (10,393
  

 

 

   

 

 

   

 

 

 

Other expense (income), net

     45       (13     21  

Stock-based compensation expense

     1,500       2,619       7,716  
  

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ (5,577   $ (3,683   $ (2,656
  

 

 

   

 

 

   

 

 

 

Adjusted EBITDA as a percentage of net revenue

     (31.3 )%      (12.1 )%      (6.5 )% 
  

 

 

   

 

 

   

 

 

 

 

12


LOGO

 

Our operating expenses, including operating loss, excluding stock-based compensation expense is as used herein, sales and distribution expenses excluding stock-based compensation expense, research and development expenses excluding stock-based compensation expense, general and administrative expenses excluding stock-based compensation expense, operating expenses excluding stock-based compensation expense and operating loss excluding stock-based compensation expense, represents our operating expenses excluding stock-based compensation which are non-cash. We believe these financial measures provide an additional metric to evaluate our cash business operations expenses. We believe these financial measures are useful to investors to evaluate the cash expense of our core business expenditures without the effect of material non-cash items such as stock-based compensation expense. Our method for calculating these financial measures may not be used by other organizations and therefore these amounts may not be directly comparable to financial measures disclosed by other organizations. As used herein, sales and distribution expense excluding stock-based compensation expense as a percentage of net revenue, research and development expenses excluding stock-based compensation expense as a percentage of net revenue, general and administrative expenses excluding stock-based compensation expense as a percentage of net revenue, operating expenses excluding stock-based compensation expense as a percentage of net revenue and operating loss excluding stock-based compensation expense as a percentage of net revenue, represents each of those financial measures divided by net revenue.

The following table provides a reconciliation of these financial measures to the most directly comparable financial measure presented in accordance with GAAP:

 

13


LOGO

 

     Three Months
Ended
September 30,
    Nine Months
Ended
September 30,
 
     2018     2019     2018     2019  
     (in thousands, except percentages)  

Sales and distribution expense

   $ 11,560     $ 17,307     $ 28,516     $ 38,409  

Add (deduct)

        

Sales and distribution stock-based compensation expense

     (5     (1,617     (11     (2,533
  

 

 

   

 

 

   

 

 

   

 

 

 

Sales and distribution expense excluding stock-based compensation expense

   $ 11,555     $ 15,690     $ 28,505       35,876  
  

 

 

   

 

 

   

 

 

   

 

 

 

Sales and distribution expense excluding stock-based compensation expense as a percentage of net revenue

     46.8     38.6     53.2     40.4

Research and development expense

   $ 790     $ 2,634     $ 2,810     $ 5,657  

Add (deduct)

        

Research and development stock-based compensation expense

     (8     (1,327     (21     (1,878
  

 

 

   

 

 

   

 

 

   

 

 

 

Research and development expense excluding stock-based compensation expense

   $ 782     $ 1,307     $ 2,789     $ 3,779  
  

 

 

   

 

 

   

 

 

   

 

 

 

Research and development expense excluding stock-based compensation expense as a percentage of net revenue

     3.2     3.2     5.2     4.3

General and administrative expense

   $ 2,767     $ 7,999     $ 8,103     $ 15,779  

Add (deduct)

        

General and administrative stock-based compensation expense

     (128     (4,772     (450     (7,424
  

 

 

   

 

 

   

 

 

   

 

 

 

General and administrative expense excluding stock-based compensation expense

   $ 2,639     $ 3,227     $ 7,653     $ 8,355  
  

 

 

   

 

 

   

 

 

   

 

 

 

General and administrative expense excluding stock-based compensation expense as a percentage of net revenue

     10.7     7.9     14.3     9.4

Total operating expenses

   $ 15,117     $ 27,940     $ 39,429     $ 59,845  

Add (deduct)

        

Total stock-based compensation expense

     (141     (7,716     (482     (11,835
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses excluding stock-based compensation expense

   $ 14,976     $ 20,224     $ 38,947     $ 48,010  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses excluding stock-based compensation expense as a percentage of net revenue

     60.7     49.8     72.7     54.1

Operating loss

   $ (4,707   $ (10,413   $ (21,772   $ (23,887

Add (deduct)

        

Total stock-based compensation expense

     141       7,716       482       11,835  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating loss excluding stock-based compensation expense

   $ (4,566   $ (2,697   $ (21,290   $ (12,052
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating loss excluding stock-based compensation expense as a percentage of net revenue

     (18.5 )%      (6.6 )%      (39.7 )%      (13.6 )% 

 

14


LOGO

 

     Three
Months
Ended
March 31,
    Three
Months

Ended
June 30,
    Three
Months
Ended
September 30,
 
     2019     2019     2019  

Sales and distribution expense

   $ 9,274     $ 11,828     $ 17,307  

Add (deduct)

      

Sales and distribution stock-based compensation expense

     (388     (528     (1,617
  

 

 

   

 

 

   

 

 

 

Sales and distribution expense excluding stock-based compensation expense

   $ 8,886     $ 11,300     $ 15,690  
  

 

 

   

 

 

   

 

 

 

Sales and distribution expense excluding stock-based compensation expense as a percentage of net revenue

     49.8     37.2     38.6

Research and development expense

   $ 1,163     $ 1,860     $ 2,634  

Add (deduct)

      

Research and development stock-based compensation expense

     (161     (390     (1,327
  

 

 

   

 

 

   

 

 

 

Research and development expense excluding stock-based compensation expense

   $ 1,002     $ 1,470     $ 1,307  
  

 

 

   

 

 

   

 

 

 

Research and development expense excluding stock-based compensation expense as a percentage of net revenue

     5.6     4.8     3.2

General and administrative expense

   $ 3,366     $ 4,414     $ 7,999  

Add (deduct)

      

General and administrative stock-based compensation expense

     (951     (1,701     (4,772
  

 

 

   

 

 

   

 

 

 

General and administrative expense excluding stock-based compensation expense

   $ 2,415     $ 2,713     $ 3,227  
  

 

 

   

 

 

   

 

 

 

General and administrative expense excluding stock-based compensation expense as a percentage of net revenue

     13.5     8.9     7.9

Total operating expenses

   $ 13,803     $ 18,102     $ 27,940  

Add (deduct)

      

Total stock-based compensation expense

     (1,500     (2,619     (7,716
  

 

 

   

 

 

   

 

 

 

Total operating expenses excluding stock-based compensation expense

   $ 12,303     $ 15,483     $ 20,224  
  

 

 

   

 

 

   

 

 

 

Total operating expenses excluding stock-based compensation expense as a percentage of net revenue

     68.9     51.0     49.8

Operating loss

   $ (7,132   $ (6,342   $ (10,413

Add (deduct)

      

Total stock-based compensation expense

     1,500       2,619       7,716  
  

 

 

   

 

 

   

 

 

 

Operating loss excluding stock-based compensation expense

   $ (5,632   $ (3,723   $ (2,697
  

 

 

   

 

 

   

 

 

 

Operating loss excluding stock-based compensation expense as a percentage of net revenue

     (31.6 )%      (12.3 )%      (6.6 )% 

 

15


LOGO

 

Quarterly Condensed Statement of Cash Flows Information

The following table provides summarized quarterly information from our condensed statement of cash flows for 2019:

 

     Three Months
Ended

March 31,
     Three Months
Ended

June 30,
     Three Months
Ended
September 30,
 
     2019      2019      2019  
     (in thousands)  

Operating activities:

        

Net loss

   $ (8,389    $ (7,625    $ (11,317

Total adjustments to reconcile net loss to net cash used in operating activities

     1,879        3,219        8,124  

Cash (used in) provided by working capital (changes in assets and liabilities)

     (5,414      41        6,337  
  

 

 

    

 

 

    

 

 

 

Cash used in operating activities

     (11,924      (4,365      3,144  

Cash used in investing activities

     (10      (11      (1,126

Financing activities:

        

Proceeds from initial public offering, less issuance costs

     —          30,902        (348

Net proceeds from (payments to) MidCap Credit Facility, including debt issuance costs

     5,520        (1,617      (5,244

All other financing activities

     (892      1,652        (266

Cash provided by (used in) financing activities

     4,628        30,937        (5,858

Effect of exchange rate on cash

     1        —          (1
  

 

 

    

 

 

    

 

 

 

Net change in cash and restricted cash for period

   $ (7,305    $ 26,561      $ (3,841
  

 

 

    

 

 

    

 

 

 

As used herein, cash burn represents the change of the net change in cash balance at each of the applicable balance sheet period adjusted for certain one-time items like our initial public offering and excluding changes in restricted cash. We use cash burn to provide an additional metric to evaluate our cash flows from our business operations. We believe cash burn is useful to investors to evaluate the cash operating performance of our business without the effect of certain one-time times (i.e., our initial public offering). Our method for calculating cash burn may not be used by other organizations and therefore our cash burn amount may not be directly comparable to the cash burn disclosed by other organizations. The following table provides a reconciliation of cash burn to the net change in cash and restricted cash for period, which is the most directly comparable financial measure presented in accordance with GAAP:

 

16


LOGO

 

     Three
Months
Ended
March 31,
     Three
Months
Ended
June 30,
     Three
Months
Ended
September 30,
 
     2019      2019      2019  
     (in thousands)  

Net change in cash and restricted cash for period

   $ (7,305    $ 26,561      $ (3,841

(deduct)

        

Proceeds from initial public offering, less issuance costs

     —          (30,902      348  

Net cash impact from mergers and acquisition activity

     —          —          1,105  

Changes in restricted cash

     250        —          —    
  

 

 

    

 

 

    

 

 

 

Cash burn

   $ (7,055    $ (4,341    $ (2,388
  

 

 

    

 

 

    

 

 

 

 

17